A
42 years; I and II
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
The POSITIVE trial—results of which were published by Partridge et al in The New England Journal of Medicine—evaluated the temporary interruption of adjuvant endocrine therapy to attempt pregnancy in young women with previous breast cancer.